IBS-C Screening, Diagnosis and Management

Presenters:

Amy Kassebaum, PA
Northwestern Memorial Hospital
Chicago, IL

Kimberly Orleck, PA
Atlanta Gastroenterology Associates
Atlanta, GA

Beginning Date: 10/31/2019
Ending Date: 10/31/2020

Webcast

Webcast must be viewed in its entirety to claim credit.

Accredited by:

Supported by:

This activity is supported by educational grants from Allergan, Inc., Ironwood Pharmaceuticals, Inc. and Salix Pharmaceuticals.

Target Audience

The on-demand presentation will target nurses, nurse practitioners and physician assistants.

Educational Objectives

  • Describe the burden of IBS and CIC on patients and the healthcare system
  • Recognize symptoms of IBS/CIC and describe strategies for diagnosing these conditions
  • Identify patients with alarm symptoms who require further diagnostic investigation
  • Describe the evidence base regarding the efficacy and safety of conventional and newer therapies for IBS and CIC
  • Differentiate among newer therapies for IBS and CIC with regard to

ANCC Accreditation:

Annenberg Center for Health Sciences is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

A maximum of 1.0 contact hours may be earned for successful completion of this activity.

AANP Accreditation:

This activity has been planned and implemented in accordance with the accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of Annenberg Center for Health Sciences and GI Health Foundation. Annenberg Center for Health Sciences is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 040207.

This program is accredited for 1.0 contact hours. Program ID #5786.

AAPA Accreditation:

    

This activity has been reviewed by the AAPA Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credits. Approval is valid for one year from 10/31/2019. PAs should only claim credit commensurate with the extent of their participation.

Disclosure of Conflicts of Interest

All individuals in control of the content of continuing education activities provided by the Annenberg Center for Health Sciences at Eisenhower (ACHS) are required to disclose to the audience any real or apparent commercial financial affiliations related to the content of the presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity. Charles Willis, Director of Continuing Education, consults for Pfizer, Inc. All other staff at the Annenberg Center for Health Sciences at Eisenhower and the Gi Health Foundation have no relationships to disclose.

Learner Assurance Statement

The Annenberg Center for Health Sciences at Eisenhower is committed to resolving all conflicts of interest issues that could arise as a result of individuals who control activity content and who have significant relationships with drug or device manufacturer(s). The Annenberg Center for Health Sciences at Eisenhower is committed to retaining only those individuals with financial interests that can be reconciled with the goals and educational integrity of the CME activity.

Faculty Disclosure

Amy Kassebaum
Consultant: Salix Pharmaceuticals (Clinical Area: Trulance for IBS-C/CC and Xifaxan for IBS-D) and Takeda (Clinical Area: Motegrity for CC);
Speakers Bureau: Salix Pharmaceuticals (Clinical Area: Trulance for IBS-C/CC and Xifaxan for IBS-D)
Kimberly Orleck
Speakers Bureau: Allergan (Clinical Area: IBS), Salix (Clinical Area: IBD/IBS) and AbbVie (Clinical Area: IBD)